The nervous system is involved in increasing resistance to treatment, which is performed by inhibiting apoptotic cells, as happens in cervical, breast, and gastric cancer by activating β2-ARs where anti-EGFR treatment and chemotherapy resistance occur [61,62,63,64]. The gene discussed is EGFR; the disease is gastric cancer.